Emilia Martignoni
Overview
Explore the profile of Emilia Martignoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrari M, Martignoni E, Blandini F, Riboldazzi G, Bono G, Marino F, et al.
Eur J Clin Pharmacol
. 2012 Apr;
68(11):1493-9.
PMID: 22527346
Purpose: To investigate the association between adverse reactions to catechol-O-methyltransferase (COMT) inhibitors and the UDP-glucuronosyltransferase 1A9 genotypes UGT1A9*1b and UGT1A9*3a, which were previously identified in individual cases of COMT inhibitor-induced...
2.
Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization
Tassorelli C, Furnari A, Buscone S, Alfonsi E, Pacchetti C, Zangaglia R, et al.
Mov Disord
. 2011 Oct;
27(2):227-35.
PMID: 21997192
Abnormal postures of the trunk are a typical feature of Parkinson's disease (PD). These include Pisa syndrome (PS), a tonic lateral flexion of the trunk associated with slight rotation along...
3.
Micieli G, Martignoni E, Sandrini G, Bono G, Nappi G
Funct Neurol
. 2011 Jul;
26(2):87-95.
PMID: 21729590
This paper traces the development of research and healthcare models in the field of cerebrovascular disorders at the C. Mondino National Institute of Neurology in Pavia, Italy. It starts with...
4.
Perrotta A, Sandrini G, Serrao M, Buscone S, Tassorelli C, Tinazzi M, et al.
Mov Disord
. 2011 Apr;
26(3):442-8.
PMID: 21462260
Background: Pain is one of the major nonmotor symptoms of Parkinson's disease. We hypothesized that Parkinson's disease patients could show an early diffuse abnormal processing of the nociceptive inputs also...
5.
Terrazzino S, Sances G, Balsamo F, Viana M, Monaco F, Bellomo G, et al.
Headache
. 2010 Sep;
50(10):1587-96.
PMID: 20807249
Objective: The aim of the present study was to evaluate a possible involvement of 2 polymorphisms of the serotonin 5HT2A receptor gene (A-1438G and C516T) as risk factors for medication...
6.
Zangaglia R, Stocchi F, Sciarretta M, Antonini A, Mancini F, Guidi M, et al.
Clin Neuropharmacol
. 2009 Nov;
33(2):61-6.
PMID: 19935405
Introduction: Slow gastric emptying decreasing levodopa (LD) bioavailability contributes to motor fluctuations in Parkinson disease (PD). Melevodopa (LD methylester), ensuring rapid duodenal absorption, has been proposed as rescue therapy for...
7.
Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, et al.
Parkinsonism Relat Disord
. 2009 Jun;
15(9):703-5.
PMID: 19482505
Mutations in the Grb10-interacting GYF protein 2 (GIGYF2) gene, within the PARK11 locus, have been nominated as a cause of Parkinson's disease in Italian and French populations. By sequencing the...
8.
Tassorelli C, Buscone S, Sandrini G, Pacchetti C, Furnari A, Zangaglia R, et al.
Parkinsonism Relat Disord
. 2009 Apr;
15(9):675-81.
PMID: 19398215
Bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an efficacious therapeutic option in the treatment of advanced Parkinson's disease (PD). The procedure may be however associated with...
9.
Blandini F, Bazzini E, Marino F, Saporiti F, Armentero M, Pacchetti C, et al.
Clin Neuropharmacol
. 2008 Nov;
32(3):133-9.
PMID: 18978486
Long-term treatment of Parkinson disease (PD) is frequently associated with l-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias (LIDs). L-DOPA-induced dyskinesias are likely due to changes in the signal transduction pathways, at the striatal level,...
10.
Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, et al.
Arch Neurol
. 2008 Sep;
65(9):1191-4.
PMID: 18779422
Objective: To determine whether pain is more frequent among people with Parkinson disease (PD) than among age-matched controls. Design: Case-control study. Patients And Methods: Logistic regression models taking into account...